Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva and Eisai end co-marketing deal
As a result, Teva Neuroscience, Teva’s US marketing subsidiary, will have sole responsibility for the marketing of Azilect in the US and Teva will no longer share profits
As a result, Teva Neuroscience, Teva’s US marketing subsidiary, will have sole responsibility for the marketing of Azilect in the US and Teva will no longer share profits
The phase I trial of CB7630, an orally active inhibitor of the steroidal enzyme 17alpha-hydroxylase/C17,20 lyase, will be conducted at the University of California San Francisco Comprehensive Cancer
In 2005, Xoma entered into a $15 million contract with the National Institute of Allergy and Infectious Diseases (NIAID) to develop cell lines, optimize production processes and manufacture
“Earlier this year HHS joined the nation’s governors for a series of state pandemic influenza summits,” said HHS Secretary Michael Leavitt. “These funds will build on the work
An infusion form of the drug is currently undergoing advanced clinical testing with the FDA. The drug is used to treat congenital emphysema, caused by an in-born deficiency
The fusion protein consists of Alfacell’s investigational anticancer drug Onconase (ranpirnase) and a humanized anti-CD22 monoclonal antibody. “This fusion protein and other new molecular forms of Onconase will
Under the two-year extension of the collaboration, which began in September 2003, Novartis will provide research funding through October 2008 in exchange for rights to license compounds developed
The FDA approval for Emend is based on two multicenter studies of 1,658 patients undergoing open abdominal surgery. Patients were randomized to receive Emend 40mg one to three
Among the potential therapeutic advantages of this approach is a dramatically increased circulatory half-life of the compound, which could give patients greater exposure to the benefits of any
The agreement sets out how the university and AstraZeneca will work together to identify new ways to treat disease and enhance discovery, preclinical and clinical research in a